Want to see AHCO full AI Analyst Report?
AHCO Stock Chart & Stats
$10.76
$0.29(2.77%)
At close: 4:00 PM EDT
$10.76
$0.29(2.77%)
Day’s Range― - ―
52-Week Range$6.14 - $13.43
Previous Close$10.7
Volume821.52K
Average Volume (3M)1.41M
Market Cap
$1.47B
Enterprise Value$3.58K
Total Cash (Recent Filing)$43.29M
Total Debt (Recent Filing)$2.07B
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Nov 10, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.68
Shares Outstanding136,054,150
10 Day Avg. Volume1,077,853
30 Day Avg. Volume1,411,350
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.89
Price to Sales (P/S)0.41
P/FCF Ratio6.14
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$10.00Price Target Upside-7.06% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.14
Revenue Forecast (FY)$3.13B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained high top-line growth across core segments demonstrates durable demand and scale in home medical equipment. Strong organic expansion (sleep, respiratory, wellness) supports revenue visibility, provides leverage for margin recovery, and underpins long-term investment in operations and digital initiatives.
Recurring Resupply RevenueA large installed patient base with recurring resupply (masks, tubing, consumables) generates predictable, recurring cash flows and high customer lifetime value. This recurring model increases revenue visibility, supports working-capital planning, and creates durable margins if adherence and reimbursement remain stable.
Operating Cash GenerationConsistently strong operating cash flow provides structural financial flexibility to fund capex, invest in digital and operational fixes, and pay down debt. Even with earnings volatility, positive cash generation supports deleveraging, refinancing actions, and targeted capital allocation over the next several quarters.
Bears Say
Margin CompressionSharp gross-margin deterioration and a sizable net loss signal structural profitability pressure. Sustained lower margins reduce retained earnings available for reinvestment and deleveraging, meaning management must deliver durable operational improvements, pricing actions, or product mix shifts to restore long-term profitability.
Elevated LeverageAbove-target leverage limits strategic flexibility and increases vulnerability to interest-cost and covenant risk if earnings remain pressured. Deleveraging depends on asset sale proceeds and sustained cash flow improvement; failure to execute could constrain growth investments and raise refinancing costs over multiple quarters.
Operational & Regulatory ConstraintsRegulatory moratorium and ramp inefficiencies on a large capitated contract limit the firm's ability to absorb fixed costs and realize expected scale benefits. Persistent operational and regulatory hurdles can prolong elevated logistics and labor expense, delaying sustainable margin recovery and cash generation.
AdaptHealth News
AHCO FAQ
What was AdaptHealth’s price range in the past 12 months?
AdaptHealth lowest stock price was $6.14 and its highest was $13.43 in the past 12 months.
What is AdaptHealth’s market cap?
AdaptHealth’s market cap is $1.47B.
When is AdaptHealth’s upcoming earnings report date?
AdaptHealth’s upcoming earnings report date is Nov 10, 2026 which is in 96 days.
How were AdaptHealth’s earnings last quarter?
AdaptHealth released its earnings results on Aug 04, 2026. The company reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.169 by -$0.009.
Is AdaptHealth overvalued?
According to Wall Street analysts AdaptHealth’s price is currently Overvalued.
Does AdaptHealth pay dividends?
AdaptHealth does not currently pay dividends.
What is AdaptHealth’s EPS estimate?
AdaptHealth’s EPS estimate is 0.09.
How many shares outstanding does AdaptHealth have?
AdaptHealth has 136,054,150 shares outstanding.
What happened to AdaptHealth’s price movement after its last earnings report?
AdaptHealth reported an EPS of $0.16 in its last earnings report, missing expectations of $0.169. Following the earnings report the stock price went down -38.042%.
Which hedge fund is a major shareholder of AdaptHealth?
Currently, no hedge funds are holding shares in AHCO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AdaptHealth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.00 (-7.06% Downside)
$10.00 (-7.06% Downside)
Hedge Fund Trend
Decreased
By 121.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 18.6%
Last 30 Days ▲ 28.1%
Last 30 Days ▲ 28.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.70%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-0.30%
Trailing 12-Months
Company Description
AdaptHealth
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
AHCO Company Deck
AHCO Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture: underlying top-line growth and strong segment performance (double-digit organic growth, expanding capitated revenue, digital adoption, strategic portfolio simplification and actions to reduce debt) are meaningful positives. However, material near-term headwinds — notably operational inefficiencies and elevated costs on a large West Coast capitated contract, an unexpected supplier price increase ($30M H2 impact), a significant reduction in full-year adjusted EBITDA guidance, a Q2 negative free cash flow driven by elevated CapEx, and a $144.2M goodwill impairment — temper the outlook. Management outlined concrete remediation steps (workflow fixes, technology/digital adoption, restructuring savings, debt paydown plans and expected elimination of stranded overhead) and expects sequential improvement toward run-rate profitability, but the magnitude of the near-term earnings and cash-flow impacts means the positives and negatives are largely in balance for the near term.View all AHCO earnings summariesAHCO Stock 12 Month Forecast
Average Price Target
$10.00
▼(-7.06% Downside)
Technical Analysis
Ownership Overview
15.12% Insiders
23.32% Mutual Funds
6.37% Other Institutional Investors
31.01% Public Companies and
Individual Investors